Table 1.
Repolarization Abnormalities in the Study Population as per 2010 ARVC Modified Task Force Criteria
| Category | Homozygotes (n=11) | Heterozygotes (n=28) | Mutation‐Negatives (n=22) | P Value |
|---|---|---|---|---|
| Inverted T waves V1 to V3, n (%) | 11/11 (100) | 0/25 (0) | 0/21 (0) | <0.001 |
| Inverted T waves V1 to V2, n (%) | 11/11 (100) | 1/25 (4) | 0/21 (0) | <0.001 |
| Inverted T waves V1 to V3+,* n (%) | 8/11 (73) | 0/25 (0) | 0/21 (0) | <0.001 |
| Inverted T waves V4 to V6, n (%) | 5/11 (45) | 0/25 (0) | 0/21 (0) | <0.001 |
| RBBB+inverted T waves V1 to V4, n (%) | 5/11 (45) | 0/25 (0) | 0/21 (0) | <0.001 |
| Inverted T waves V2 to V3, n (%) | 11/11 (100) | 0/25 (0) | 0/21 (0) | <0.001 |
| TFC repolarization (major), n (%) | 11/11 (100) | 0/25 (0) | 0/21 (0) | <0.001 |
| TFC repolarization (minor), n (%) | 0/11 (0) | 1/25 (4) | 0/21 (0) | 1.0 |
ARVC indicates arrhythmogenic right ventricular cardiomyopathy; RBBB, right bundle branch block; TFC, Task Force Criteria.
*
T‐wave inversion in V1 to V3 and beyond.